Through the Center for Multisite Studies, NYU Langone can help manage a coordinating center for multisite studies.

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it ...

This study presents a valuable finding on mutations in ZNF217, ZNF703, and ZNF750 through 23 breast cancer samples alongside matched normal tissues in Kenyan breast cancer patients. The evidence ...

As a kid, you daydream about the kind of job you'd like to have as you get older. And unsurprisingly, what makes a suitable ...

Q3 2025 Earnings Call October 31, 2025 8:00 AM EDTCompany ParticipantsMegan Carlson - Interim CFO, Chief Accounting ...

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP ...

Photocure ASA (($NO:PHO)) has held its Q3 earnings call. Read on for the main highlights of the call. Photocure ASA’s recent earnings call ...